Document is current
Any future updates will be listed below
-
Authors
França, Gustavo S.
Baron, Maayan
King, Benjamin R.
Bossowski, Jozef P.
Bjornberg, Alicia https://orcid.org/0000-0002-9683-4071
Pour, Maayan
Rao, Anjali https://orcid.org/0000-0001-8815-9865
Patel, Ayushi S.
Misirlioglu, Selim
Barkley, Dalia https://orcid.org/0000-0001-6537-5557
Tang, Kwan Ho https://orcid.org/0000-0001-7729-5159
Dolgalev, Igor https://orcid.org/0000-0003-4451-126X
Liberman, Deborah A. https://orcid.org/0000-0002-5029-0611
Avital, Gal
Kuperwaser, Felicia
Chiodin, Marta
Levine, Douglas A.
Papagiannakopoulos, Thales https://orcid.org/0000-0002-2251-1624
Marusyk, Andriy https://orcid.org/0000-0002-0087-9575
Lionnet, Timothée https://orcid.org/0000-0003-1508-0202
Yanai, Itai https://orcid.org/0000-0002-8438-2741
- License Information
-
More Information
Article History
Received: 17 June 2022
Accepted: 7 June 2024
First Online: 10 July 2024
Competing interests
: D.A. Levine is a founder of Resident Diagnostics and is a full-time employee of Merck & Co. T.P. received funding from Dracen Pharmaceuticals, Kymera Therapeutics, Bristol Myers Squibb and Agios Pharmaceuticals not related to the submitted work. T.P. consulted for Vividion Therapeutics, Tohoku University and Faeth Therapeutics.
